Akoya Biosciences Inc (NAS:AKYA)
$ 2.45 -0.1 (-3.92%) Market Cap: 126.39 Mil Enterprise Value: 165.50 Mil PE Ratio: 0 PB Ratio: 9.11 GF Score: 46/100

Q3 2024 Akoya Biosciences Inc Earnings Call Transcript

Nov 14, 2024 / 10:00PM GMT
Release Date Price: $3.13 (-2.49%)
Operator

Hello and thank you for standing by. Welcome to Alcoa Bioscience. This third quarter 2024 earnings conference call.

At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question and answer session to ask the question during the session. You will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised to withdraw your question. Please press star 11 again.

I would now like to hand the conference over to Priam Shaw, head of Investor Relations. You may begin.

Priyam Shah
Akoya Biosciences Inc - Head of Investor Relations

Thank you operator and thank you to everyone who's joining us today on this call. I'm Priam Shah, head of Investor Relations at Ecoa Biosciences on the call. Today. We have Brian mckelly, Chief Executive Officer and Johnny Ek, Chief Financial Officer.

Earlier today, aqua released financial results for the third quarter ended September 30th 2024.

A copy of the press release is available on the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot